LucasPye BIO

About:

A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.

Website: https://lucaspyebio.com

Twitter/X: lucaspyebio

Description:

LucasPye BIO, LLC (LPB) is a Contract Development Manufacturing Organization (CDMO) that will be located in the Philadelphia, PA. We are currently in Start-Up phase. LPB will manufacture biological drug products, in the form of bulk drug substances (BDS), on behalf of it's clients per cGMP, within our clients'​ timelines, and below market price. Our operations will include BDS manufacturing for mammalian cell lines as well as viral vectors and gene vectors. LPB will utilize High-Quality Single-Use Equipment, Inline-PAT, Automation (minimizing human operations), Multivariate Analytics (MVA), e-Documentation, and Real-Time Quality Assurance Operations. LucasPye BIO will be the 1st Biologics CDMO to have: - Virtual Business Operations - E-Documentation Cloud Software (including mobile/web apps) - Commercial Life Science Co-Working / Wet Lab Facility LucasPye BIO will be the 1st to offer: - Regulatory Services for drafting documentation for IND & BLAs as well as post-marketing documentation - Placement of biologics on the prescription menus for Medical Insurers, i.e. Blue Cross Blue Shield, Kaiser Permanente, etc. - No Premium Charges for Raw Materials & Consumable Equipment utilized in the customer's bioprocess If you are interested in learning more about our company offerings (including dates for doors opening, hiring, etc.), please contact Tia Lyles-Williams - Founder & CEO of LucasPye BIO, LLC

Total Funding Amount:

$1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Philadelphia, Pennsylvania, United States

Founded Date:

2018-10-01

Contact Email:

Tia(AT)LucasPyeBIO.com

Founders:

Tia Lyles-Williams

Number of Employees:

11-50

Last Funding Date:

2019-05-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai